CRBU · Caribou Biosciences, Inc. · Executive Compensation
$0.38
-0.01 (-2.69%)
At close · Nov 12
Return incl. dividend (before tax)
Market Cap
$41.08M
Shares
108.04M
Volume · Nov 12
1.54M
Avg daily vol (3M)
2.72M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Rachel Haurwitz | President and chief executive officer | $1,840,965 |
| Sriram Ryali | M.B.A. Chief financial officer | $1,029,413 |
| Barbara McClung | Chief legal officer | $919,574 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Rachel Haurwitz | President and chief executive officer | $4,213,245 |
| Tim Kelly | M.B.A. Chief technology officer | $1,913,370 |
| Barbara McClung | Chief legal officer | $1,612,819 |
| Steven Kanner | Chief scientific officer | $1,612,819 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Rachel Haurwitz | President and chief executive officer | $3,116,547 |
| Syed Rizvi | Former chief medical officer | $1,268,277 |
| Steven Kanner | Chief scientific officer | $1,217,807 |
| Barbara McClung | Chief legal officer | $1,217,807 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Syed Rizvi | Former chief medical officer | $2,388,492 |
| Ruhi Khan | M.B.A. Chief business officer | $1,038,077 |
| Rachel Haurwitz | President and chief executive officer | $833,468 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Rachel Haurwitz | President and chief executive officer | $6,249,919 |
| Jason O’Byrne | M.B.A. Chief financial officer | $3,449,030 |
| Jason V. O'Byrne | M.B.A. Chief financial officer | $3,449,030 |
| Barbara McClung | Chief legal officer and corporate secretary | $2,743,054 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Rachel Haurwitz | President and chief executive officer | $663,900 |
| Barbara McClung | Chief legal officer and corporate secretary | $504,150 |
| Jason O’Byrne | M.B.A. Chief financial officer | — |
| Jason V. O'Byrne | M.B.A. Chief financial officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ryan Fischesser | interim principal accounting officer | Terminated | 2025-01-02 |
| Sriram Ryali | Chief Financial Officer ("CFO") | Appointed | 2025-01-02 |
| Ryan Fischesser | principal accounting officer | Appointed | 2024-09-03 |
| Jason O'Byrne | Chief Financial Officer | Resigned | 2024-09-03 |
| Syed Rizvi, M.D. | Chief Medical Officer | Terminated | 2023-12-12 |
| Jason V. O'Byrne | principal accounting officer | Appointed | 2022-12-16 |
Leadership
- Rachel Haurwitz CEO, Board Member
- Sriram Ryali CFO
- Tim Kelly CTO
- Jason V. O'Byrne Chief Accounting Officer
- Ryan Fischesser Chief Accounting Officer
- Andrew Guggenhime Board Member
- Dara Richardson-Heron Board Member
- Dara Richardson-Heron, M.D. Board Member
- David Johnson Board Member
- Nancy C. Whiting, Pharm. D. Board Member
- Nancy Whiting Board Member
- Natalie Sacks Board Member
- Ran Zheng Board Member
- Scott Braunstein Board Member
Key facts
CIK
1619856
CUSIP
142038108
13F (30d)
94 filings
81 filers
Visit website
Investor relations